feed,title,long_url,short_url
Benzinga,"Infosys Clocks 21% Top-Line Growth In Q2, Lifts FY22 Revenue Outlook",https://benzinga.com/news/earnings/21/10/23351466/infosys-clocks-21-top-line-growth-in-q2-lifts-fy22-revenue-outlook,https://j.mp/3aELUPb
Benzinga,"The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal",https://benzinga.com/general/biotech/21/10/23351993/the-daily-biotech-pulse-fda-nod-for-lilly-regulus-slumps-on-study-discontinuation-obseva-strikes-,https://j.mp/2YQCNIX
